Over the last decade, a number of transcription factors and coregulators have been characterized as important regulators of energy homeostasis. Despite these recent advances, relatively few molecular targets have been described that control energy balance in a holistic manner. Interestingly, our recently published data and preliminary studies now show that Steroid Receptor Coactivator-2 (SRC-2) is involved not only in energy dissipation, but also in the dietary absorption of fat. SRC-2 achieves this function through the coordinated regulation of a hepatic gene cassette, which includes the Bile Salt Export Pump (BSEP) that is necessary for bile acid secretion and reabsorption. Interfering with this process by hepatic-specific ablation of SRC-2 results in fat malabsorption in the gut, which can be rescued by dietary administration of bile acids, or by hepatic re-expression of BSEP. Furthermore, SRC-2 not only modulates the energy balance at both ends of the energy equation (accretion and dissipation), but itself is also sensitive to changes in energy status. In response to low cellular energy, we show that AMPK phosphorylates SRC-2, which increases its intrinsic transcriptional activity and drives these two metabolic regulators to target genes necessary for energy intake. Moreover, we found that SRC-2 enhances AMPK phosphorylation of histones, an event that has been reported to enhance target gene expression. Collectively, these findings form the basis of our PPG renewal for Project 1, where we hypothesize that SRC-2 functions as a master regulator of energy homeostasis in coordination with AMPK.

Public Health Relevance

The precise mechanistic underpinnings ofthe AMPK/SRC-2 'energy sensor'axis are completely unexplored, as Project 1 is based upon entirely new findings. Regulation of whole body energetics has profound implications for the exploding co-morbidities of the metabolic syndrome that plague our country. As such, detailing such molecular pathways would open new intervention avenues for developing small molecule inhibitors to treat these metabolic diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
2P01DK059820-11A1
Application #
8419635
Study Section
Special Emphasis Panel (ZDK1-GRB-D (M1))
Project Start
Project End
Budget Start
2012-09-14
Budget End
2013-06-30
Support Year
11
Fiscal Year
2012
Total Cost
$370,385
Indirect Cost
$133,717
Name
Baylor College of Medicine
Department
Type
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Lee, Hui-Ju; Kao, Chung-Yang; Lin, Shih-Chieh et al. (2017) Dysregulation of nuclear receptor COUP-TFII impairs skeletal muscle development. Sci Rep 7:3136
Rohira, Aarti D; Yan, Fei; Wang, Lei et al. (2017) Targeting SRC Coactivators Blocks the Tumor-Initiating Capacity of Cancer Stem-like Cells. Cancer Res 77:4293-4304
Xu, Y; Qin, L; Sun, T et al. (2017) Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression. Oncogene 36:1157-1166
Xu, Yong; O'Malley, Bert W; Elmquist, Joel K (2017) Brain nuclear receptors and body weight regulation. J Clin Invest 127:1172-1180
Zhao, Fei; Franco, Heather L; Rodriguez, Karina F et al. (2017) Elimination of the male reproductive tract in the female embryo is promoted by COUP-TFII in mice. Science 357:717-720
Yi, Ping; Wang, Zhao; Feng, Qin et al. (2017) Structural and Functional Impacts of ER Coactivator Sequential Recruitment. Mol Cell 67:733-743.e4
Xie, Xin; Wu, San-Pin; Tsai, Ming-Jer et al. (2017) The Role of COUP-TFII in Striated Muscle Development and Disease. Curr Top Dev Biol 125:375-403
Xie, Xin; Tsai, Sophia Y; Tsai, Ming-Jer (2016) COUP-TFII regulates satellite cell function and muscular dystrophy. J Clin Invest 126:3929-3941
Wang, Lei; Lonard, David M; O'Malley, Bert W (2016) The Role of Steroid Receptor Coactivators in Hormone Dependent Cancers and Their Potential as Therapeutic Targets. Horm Cancer 7:229-35
Wang, Leiming; Xu, Mafei; Qin, Jun et al. (2016) MPC1, a key gene in cancer metabolism, is regulated by COUPTFII in human prostate cancer. Oncotarget 7:14673-83

Showing the most recent 10 out of 180 publications